Predictors of severe or lethal COVID-19, including Angiotensin Converting Enzyme inhibitors and Angiotensin II Receptor Blockers, in a sample of infected Italian citizens.

Francesca BraviMaria Elena FlaccoTiziano CarradoriCarlo Alberto VoltaGiuseppe CosenzaAldo De TogniCecilia Acuti MartellucciGiustino ParrutiLorenzo MantovaniLamberto Manzoli

Published in: PloS one (2020)

No association was found between COVID-19 severity and treatment with ARBs and/or ACEi, supporting the recommendation to continue medication for all patients unless otherwise advised by their physicians.

Keyphrases

angiotensin converting enzyme
angiotensin ii
coronavirus disease
sars cov
vascular smooth muscle cells
end stage renal disease
primary care
ejection fraction
chronic kidney disease
healthcare
prognostic factors
peritoneal dialysis
respiratory syndrome coronavirus
combination therapy
drug induced